Aardvark Therapeutics, Inc. (AARD)
CIK 1774857 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aardvark Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 144 | 0001950047-26-009373 |
| Sep 11, 2026 | 4 | 0001193125-26-389564 |
| Sep 10, 2026 | 144 | 0001950047-26-009316 |
| Aug 21, 2026 | 4 | 0001193125-26-361482 |
| Aug 21, 2026 | 4 | 0001193125-26-361489 |
| Aug 21, 2026 | 4 | 0001193125-26-361486 |
| Aug 21, 2026 | 4 | 0001193125-26-361481 |
| Aug 17, 2026 | 8-K | 0001193125-26-354053 |
| Aug 11, 2026 | 8-K | 0001193125-26-344978 |
| Aug 11, 2026 | 10-Q | 0001193125-26-344987 |
| Jul 10, 2026 | DEF 14A | 0001193125-26-300874 |
| Jul 10, 2026 | ARS | 0001193125-26-300897 |
| Jun 29, 2026 | PRE 14A | 0001193125-26-288409 |
| Jun 12, 2026 | 8-K | 0001193125-26-269377 |
| May 14, 2026 | 8-K | 0001193125-26-224069 |
| May 7, 2026 | 8-K | 0001193125-26-210664 |
| May 7, 2026 | 10-Q | 0001193125-26-210675 |
| Apr 3, 2026 | 424B5 | 0001193125-26-142105 |
| Apr 3, 2026 | EFFECT | 9999999995-26-001083 |
| Mar 24, 2026 | 8-K | 0001193125-26-120164 |
| Mar 24, 2026 | S-8 | 0001193125-26-120120 |
| Mar 23, 2026 | 10-K | 0001193125-26-119770 |
| Mar 23, 2026 | 8-K | 0001193125-26-119727 |
| Mar 23, 2026 | S-3 | 0001193125-26-119973 |
| Feb 27, 2026 | 8-K | 0001193125-26-082787 |